CIK 0001810182
- Non-accelerated filer
- Smaller reporting company
ALX ONCOLOGY HOLDINGS INC
Sign in to watch- Ticker
- ALXO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 850642577
- Phone
- +1 650-466-7125
- Business address
- 323 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 42,000 shares (grant or award)
- 4 Open-market sale SVP, FINANCE AND CAO sold 550 shares at $1.15 ($633)
- 4 Open-market sale PRESIDENT & CSO sold 1,326 shares at $1.15 ($1,525)
- 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 2,159 shares at $1.15 ($2,483)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Interim CFO sold 2,221 shares at $1.80 ($3,998)
- 4 Open-market sale Interim CFO sold 1,426 shares at $1.58 ($2,253)
- 4 Open-market sale PRESIDENT & CSO sold 10,796 shares at $1.58 ($17,060)
Page 3 of 11 · 213 filings